Who owns the FRAXLANZA trademark?

The FRAXLANZA trademark is owned by Larimar Therapeutics, Inc..

What class is the FRAXLANZA trademark registered in?

The FRAXLANZA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for FRAXLANZA?

The USPTO serial number for FRAXLANZA is 98743154.

What is the registration number for FRAXLANZA?

FRAXLANZA is registered under USPTO registration number 0.

Sealvo

Home Search: FRAXLANZAFRAXLANZA #98743154

Back

Updated Oct 25, 2026·37 searches this week

View on USPTO TSDR Find similar marks

FRA

USPTO Trademark Record

PENDING

FRAXLANZA

SN 98743154·Reg 0·Filed Sep 10, 2024

Owner Larimar Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

FRAXLANZA (Serial No. 98743154), Registration No. 0, is a pending US trademark filed on Sep 10, 2024 by Larimar Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Statement of Use due: December 03, 202639 days remaining

Mark Intelligence

FRAXLANZA (Reg. #0) is a pending US trademark that was filed in 2024 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 10, 2024

SERIAL

98743154

REG#

Filing Information

StatusPENDING

Filing DateSep 10, 2024

Serial Number98743154

Registration No.0

Status DateMay 29, 2026

Published for OppositionApr 08, 2025

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1892344

480Nov 21, 2025

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

23 events

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 30, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

May 29, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

May 29, 2026

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

May 29, 2026

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 02, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Dec 01, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Dec 01, 2025

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Dec 01, 2025

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 03, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 08, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 08, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 02, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Mar 17, 2025

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Mar 17, 2025

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 17, 2025

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Mar 17, 2025

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 17, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Mar 12, 2025

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Mar 12, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 12, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 12, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION ENTERED

Sep 10, 2024

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 10, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by Larimar Therapeutics, Inc.

Additional USPTO filings from the same owner.

LAR

LARIMAR THERAPEUTICS

90059153

LARIMAR THERAPEUTICS, INC.

REGISTERED

LAR

LARIMAR

88446118

LARIMAR THERAPEUTICS, INC.

REGISTERED

UFR

UFRAXTA

98743106

Larimar Therapeutics, Inc.

PENDING

HUF

HUFRAXTA

98743134

Larimar Therapeutics, Inc.

PENDING

Other Marks by Keith Toms, Esq.

Additional USPTO filings handled by the same attorney of record.

OMI

OMICS-GUARD

98854053

REGISTERED

DUA

DUALCLEAN

98945416

REGISTERED

AUG

AUGIE

78563869

REGISTERED

LLE

L LEMO

79171650

REGISTERED

FRAXLANZA

Run a conflict check

Other Marks by Larimar Therapeutics, Inc.

Other Marks by Keith Toms, Esq.

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company